Revenue (Details) - USD ($) |
1 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2015 |
Dec. 31, 2015 |
|
| Revenue | ||
| Collaboration revenue | $ 6,250,000 | |
| Allergan | ||
| Revenue | ||
| Collaboration revenue | $ 6,300,000 | |
| Nonrefundable upfront fee | $ 10,000,000 |
| X | ||||||||||
- Definition Revenue earned during the period from a research collaboration with a pharmaceutical company. No definition available.
|
| X | ||||||||||
- Definition Represents the payment received to fund the expansion of a clinical trial. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|